PTGX vs WAB · rev $269.8M vs P/E 38, rev $3.18B
Protagonist Therapeutics Inc (PTGX) versus Westinghouse Air Brake Technologies Corp (WAB) — a side-by-side from cached financials, not a winner call.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Westinghouse Air Brake Technologies Corp (WAB) is a railroads company listed on NYSE.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
Latest reported WAB revenue for 2026-06-30 was $3.18B. Net income was $395.0M. Revenue was up 7.8% from 2026-03-31 to 2026-06-30. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
PTGX currently screens at market cap $7.25B. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
Not investment advice. Open the PTGX and WAB stock pages for the full models.
Not investment advice.